Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Bitcoin retraced after a volatile stretch, pushing traders to rethink income-focused strategies. This piece breaks do...
Energy income investors face a critical test as crude prices swing. This report examines the dividend safety check: e...
Bitcoin is moving beyond ETFs into a new class of financial primitives, powering insurance reserves, margin for trade...
In a fluctuating rate environment, retirees eyeing quarterly income are increasingly turning to the Vanguard Real Est...
Yum Brands agreed to divest Pizza Hut for about $2.7 billion, splitting the brand between LongRange Capital outside C...
Deadly protests in Pakistan’s Karachi and Gilgit-Baltistan have left at least 22 dead and more than 120 injured as cr...
Is 2026 a year for nostalgia in travel? This guide breaks down how nostalgia shapes trips, how to budget for memory-d...
A new look at the equipment carried by WWII paratroopers sheds light on how historical burdens shape modern defense b...
US spot Bitcoin ETFs posted a tough week, with persistent outflows until July 2 when buyers returned briefly. Ethereu...
As AI and cloud demand shape the tech landscape in early 2026, investors debate whether broad exposure through XLK or...
Bank earnings just dropped fresh clues about how Americans are spending, borrowing, and saving. This deep dive breaks...